Literature DB >> 26120215

Design and Synthesis of (2-(5-Chloro-2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)cyclopropyl)methanamine as a Selective Serotonin 2C Agonist.

Jianjun Cheng1, Patrick M Giguere2, Wei Lv1, Bryan L Roth2, Alan P Kozikowski1.   

Abstract

A conformationally restricted analog of a selective cyclopropane-bearing serotonin 2C agonist was designed and synthesized. A 2,2-dimethyl-2,3-dihydrobenzofuran scaffold was investigated as a constrained variant of a biologically active isopropyl phenyl ether. Construction of the required dimethyl-2,3-dihydrobenzofuran intermediate began using a procedure that relied on a microwave-assisted alkylation reaction. The synthesis of the designed compound as its HCl salt is reported in a total of 12 steps and 17% overall yield. Biological evaluation revealed the constrained analog to be a selective serotonin 2C agonist with modest potency.

Entities:  

Keywords:  Agonist; Benzofuran; Cyclopropylmethanamine; Serotonin 2C

Year:  2015        PMID: 26120215      PMCID: PMC4479288          DOI: 10.1016/j.tetlet.2015.01.060

Source DB:  PubMed          Journal:  Tetrahedron Lett        ISSN: 0040-4039            Impact factor:   2.415


  13 in total

1.  Rational Drug Design Leading to the Identification of a Potent 5-HT(2C) Agonist Lacking 5-HT(2B) Activity.

Authors:  Gang Chen; Sung Jin Cho; Xi-Ping Huang; Niels H Jensen; Andreas Svennebring; Maria F Sassano; Bryan L Roth; Alan P Kozikowski
Journal:  ACS Med Chem Lett       Date:  2011-10-10       Impact factor: 4.345

Review 2.  The potential use of selective 5-HT2C agonists in treating obesity.

Authors:  Brian M Smith; William J Thomsen; Andrew J Grottick
Journal:  Expert Opin Investig Drugs       Date:  2006-03       Impact factor: 6.206

3.  Pilot study of zatosetron (LY277359) maleate, a 5-hydroxytryptamine-3 antagonist, in the treatment of anxiety.

Authors:  W T Smith; P D Londborg; S L Blomgren; G D Tollefson; M E Sayler
Journal:  J Clin Psychopharmacol       Date:  1999-04       Impact factor: 3.153

Review 4.  Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs.

Authors:  Herbert Y Meltzer; Bryan L Roth
Journal:  J Clin Invest       Date:  2013-12-02       Impact factor: 14.808

5.  Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment.

Authors:  Xi-Ping Huang; Vincent Setola; Prem N Yadav; John A Allen; Sarah C Rogan; Bonnie J Hanson; Chetana Revankar; Matt Robers; Chris Doucette; Bryan L Roth
Journal:  Mol Pharmacol       Date:  2009-07-01       Impact factor: 4.436

Review 6.  Hallucinogens.

Authors:  David E Nichols
Journal:  Pharmacol Ther       Date:  2004-02       Impact factor: 12.310

7.  Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.

Authors:  D W Robertson; W B Lacefield; W Bloomquist; W Pfeifer; R L Simon; M L Cohen
Journal:  J Med Chem       Date:  1992-01-24       Impact factor: 7.446

Review 8.  Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications.

Authors:  Kelly A Berg; William P Clarke; Kathryn A Cunningham; Umberto Spampinato
Journal:  Neuropharmacology       Date:  2008-06-17       Impact factor: 5.250

9.  The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site.

Authors:  A Pazos; D Hoyer; J M Palacios
Journal:  Eur J Pharmacol       Date:  1984-11-27       Impact factor: 4.432

Review 10.  The expanded biology of serotonin.

Authors:  Miles Berger; John A Gray; Bryan L Roth
Journal:  Annu Rev Med       Date:  2009       Impact factor: 16.048

View more
  5 in total

1.  Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51.

Authors:  Wei Lv; Brian Budke; Michal Pawlowski; Philip P Connell; Alan P Kozikowski
Journal:  J Med Chem       Date:  2016-04-21       Impact factor: 7.446

Review 2.  Recent Advances in Phthalan and Coumaran Chemistry.

Authors:  Efimov Ilya; Larisa Kulikova; Erik V Van der Eycken; Leonid Voskressensky
Journal:  ChemistryOpen       Date:  2018-11-23       Impact factor: 2.911

3.  Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT2C Modulators.

Authors:  Juhyeon Kim; Hanbyeol Jo; Hyunseung Lee; Hyunah Choo; Hak Joong Kim; Ae Nim Pae; Yong Seo Cho; Sun-Joon Min
Journal:  Molecules       Date:  2017-08-26       Impact factor: 4.411

4.  A Novel G Protein-Biased and Subtype-Selective Agonist for a G Protein-Coupled Receptor Discovered from Screening Herbal Extracts.

Authors:  Bingjie Zhang; Simeng Zhao; Dehua Yang; Yiran Wu; Ye Xin; Haijie Cao; Xi-Ping Huang; Xiaoqing Cai; Wen Sun; Na Ye; Yueming Xu; Yao Peng; Suwen Zhao; Zhi-Jie Liu; Guisheng Zhong; Ming-Wei Wang; Wenqing Shui
Journal:  ACS Cent Sci       Date:  2020-01-23       Impact factor: 14.553

5.  Synthesis and Biological Evaluation of Disubstituted Pyrimidines as Selective 5-HT2C Agonists.

Authors:  Juhyeon Kim; Yoon Jung Kim; Ashwini M Londhe; Ae Nim Pae; Hyunah Choo; Hak Joong Kim; Sun-Joon Min
Journal:  Molecules       Date:  2019-09-05       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.